Skip to main content
Loading page, please wait…
HomeCurrent AffairsEditorialsGovt SchemesLearning ResourcesUPSC SyllabusPricingAboutBest UPSC AIUPSC AI ToolAI for UPSCUPSC ChatGPT

© 2026 Vaidra. All rights reserved.

PrivacyTerms
Vaidra Logo
Vaidra

Top 4 items + smart groups

UPSC GPT
New
Current Affairs
Daily Solutions
Daily Puzzle
Mains Evaluator

Version 2.0.0 • Built with ❤️ for UPSC aspirants

WHO Examines Vaccine Options as Ebola Outbreak Escalates in DRC — 131 Dead, 500+ Infected

The WHO is evaluating vaccine and treatment options as a new Ebola outbreak in the DRC, caused by the Bundibugyo strain, has killed 131 and infected over 500 people. With no approved vaccine for this strain, the agency is coordinating experts, supplies, and NGOs to contain the spread while prioritising candidates like Ervebo for future use.
Overview : The WHO is assessing candidate vaccines and treatments to curb a rapidly spreading Ebola outbreak in the Democratic Republic of Congo (DRC). The surge has killed 131 people and infected over 500 , prompting an international health emergency declaration. Key Developments WHO representative Anne Ancia said the agency is reviewing all candidate vaccines and therapeutics. Tedros Adhanom Ghebreyesus expressed deep concern and will convene an emergency meeting on the crisis. There is no approved vaccine for the Bundibugyo strain causing the current outbreak. Existing vaccines target the Zaire strain , and pre‑qualified vaccines cannot be used now. The vaccine candidate Ervebo is under review and may become available after about two months. Important Facts This is the 17th Ebola outbreak in the DRC. The deadliest DRC outbreak (2018‑2020) claimed 2,300 lives . WHO has deployed more than 40 experts and sent 12 tonnes of supplies, including PPE , from Kinshasa and Nairobi. Collaboration with Doctors Without Borders is underway to set up treatment centres. The WHO technical advisory group will meet to prioritise vaccine candidates. UPSC Relevance Understanding the WHO’s role highlights the importance of global health governance (GS1). The distinction between virus strains (Bundibugyo vs. Zaire) illustrates challenges in vaccine development and deployment , a recurring theme in health‑policy questions. The coordination with NGOs like Doctors Without Borders underscores the need for public‑private partnerships in disaster response, relevant to GS2 (Polity) and GS4 (Ethics). The emergency meeting convened by the Director‑General reflects decision‑making mechanisms in international organisations, a typical UPSC case study. Way Forward WHO will finalise vaccine prioritisation, aim to secure Ervebo or other candidates, and expand laboratory capacity. Strengthening PPE supplies and field teams remains critical. Continuous monitoring and rapid response are essential to prevent the outbreak from extending beyond the projected two‑month window.
  1. Home
  2. Prepare
  3. Current Affairs
  4. WHO Examines Vaccine Options as Ebola Outbreak Escalates in DRC — 131 Dead, 500+ Infected
Must Review
Login to bookmark articles
Login to mark articles as complete

Overview

gs.gs280% UPSC Relevance

Full Article

<p><strong>Overview</strong>: The <span class="key-term" data-definition="World Health Organization — UN agency that coordinates international health work, monitors disease outbreaks, and provides technical guidance (GS1: Health, GS3: International Institutions)">WHO</span> is assessing candidate vaccines and treatments to curb a rapidly spreading <span class="key-term" data-definition="Ebola — A viral haemorrhagic fever with high fatality, posing major public‑health challenges (GS1: Health)">Ebola</span> outbreak in the Democratic Republic of Congo (DRC). The surge has killed <strong>131 people</strong> and infected over <strong>500</strong>, prompting an international health emergency declaration.</p> <h3>Key Developments</h3> <ul> <li>WHO representative <span class="key-term" data-definition="Anne Ancia — WHO’s senior official for the DRC, responsible for field coordination (GS1: Health)">Anne Ancia</span> said the agency is reviewing all candidate vaccines and therapeutics.</li> <li><span class="key-term" data-definition="Tedros Adhanom Ghebreyesus — Director‑General of WHO, leading global health policy (GS1: Health)">Tedros Adhanom Ghebreyesus</span> expressed deep concern and will convene an emergency meeting on the crisis.</li> <li>There is no approved vaccine for the <span class="key-term" data-definition="Bundibugyo strain — A variant of Ebola virus not covered by existing vaccines, increasing response complexity (GS1: Health)">Bundibugyo strain</span> causing the current outbreak.</li> <li>Existing vaccines target the <span class="key-term" data-definition="Zaire strain — The original Ebola virus identified in 1976; current licensed vaccine Ervebo is for this strain (GS1: Health)">Zaire strain</span>, and pre‑qualified vaccines cannot be used now.</li> <li>The vaccine candidate <span class="key-term" data-definition="Ervebo — WHO‑approved vaccine for Zaire Ebola, requiring two months for deployment (GS1: Health)">Ervebo</span> is under review and may become available after about two months.</li> </ul> <h3>Important Facts</h3> <ul> <li>This is the <strong>17th</strong> Ebola outbreak in the DRC.</li> <li>The deadliest DRC outbreak (2018‑2020) claimed <strong>2,300 lives</strong>.</li> <li>WHO has deployed more than <strong>40 experts</strong> and sent <strong>12 tonnes</strong> of supplies, including <span class="key-term" data-definition="Personal Protective Equipment — Gear such as masks, gloves, and gowns that protect health workers from infection (GS3: Health Infrastructure)">PPE</span>, from Kinshasa and Nairobi.</li> <li>Collaboration with <span class="key-term" data-definition="Doctors Without Borders — International medical humanitarian NGO that provides emergency care in conflict zones (GS2: Polity, GS4: Ethics)">Doctors Without Borders</span> is underway to set up treatment centres.</li> <li>The WHO technical advisory group will meet to prioritise vaccine candidates.</li> </ul> <h3>UPSC Relevance</h3> <p>Understanding the WHO’s role highlights the importance of <strong>global health governance</strong> (GS1). The distinction between virus strains (Bundibugyo vs. Zaire) illustrates challenges in <strong>vaccine development and deployment</strong>, a recurring theme in health‑policy questions. The coordination with NGOs like Doctors Without Borders underscores the need for <strong>public‑private partnerships</strong> in disaster response, relevant to GS2 (Polity) and GS4 (Ethics). The emergency meeting convened by the Director‑General reflects decision‑making mechanisms in international organisations, a typical UPSC case study.</p> <h3>Way Forward</h3> <p>WHO will finalise vaccine prioritisation, aim to secure <span class="key-term" data-definition="Ervebo — WHO‑approved vaccine for Zaire Ebola, requiring two months for deployment (GS1: Health)">Ervebo</span> or other candidates, and expand laboratory capacity. Strengthening <span class="key-term" data-definition="Personal Protective Equipment — Gear such as masks, gloves, and gowns that protect health workers from infection (GS3: Health Infrastructure)">PPE</span> supplies and field teams remains critical. Continuous monitoring and rapid response are essential to prevent the outbreak from extending beyond the projected two‑month window.</p>
Read Original on hindu

WHO’s emergency vaccine review underscores strain‑specific gaps in global Ebola response.

Key Facts

  1. The DRC has reported over 500 confirmed Ebola cases and 131 deaths in the current outbreak (2026).
  2. This is the 17th Ebola outbreak in the DRC; the deadliest (2018‑2020) claimed about 2,300 lives.
  3. The outbreak is caused by the Bundibugyo strain, which is not covered by the licensed Zaire‑strain vaccine Ervebo.
  4. WHO has deployed more than 40 experts and sent 12 tonnes of PPE, medicines and equipment to the affected zones.
  5. WHO Director‑General Tedros Adhanom Ghebreyesus will convene an emergency meeting to prioritise vaccine candidates.
  6. Ervebo, the WHO‑approved Zaire‑strain vaccine, could be available only after roughly two months of preparation.

Background & Context

Ebola outbreaks test global health governance. The WHO, under the International Health Regulations, coordinates vaccine assessment, supplies and technical advice, while NGOs like MSF provide on‑ground care. The strain mismatch highlights the need for flexible vaccine platforms and rapid regulatory pathways.

UPSC Syllabus Connections

Prelims_GS•International Current AffairsGS2•Important international institutions and agenciesEssay•Youth, Health and WelfarePrelims_GS•Biology and Health

Mains Answer Angle

GS2 – International Relations: Discuss how the WHO’s emergency mechanisms and public‑private partnerships shape global health security, especially when existing vaccines are strain‑specific.

Analysis

Practice Questions

GS2
Easy
Prelims MCQ

Ebola outbreak in DRC, vaccine strain specificity

1 marks
3 keywords
GS2
Medium
Mains Short Answer

WHO emergency response, International Health Regulations

10 marks
5 keywords
GS2
Hard
Mains Essay

Vaccine development, global health governance, public‑private partnership

250 marks
5 keywords
Related:Daily•Weekly

Loading related articles...

Loading related articles...

Tip: Click articles above to read more from the same date, or use the back button to see all articles.

Quick Reference

Key Insight

WHO’s emergency vaccine review underscores strain‑specific gaps in global Ebola response.

Key Facts

  1. The DRC has reported over 500 confirmed Ebola cases and 131 deaths in the current outbreak (2026).
  2. This is the 17th Ebola outbreak in the DRC; the deadliest (2018‑2020) claimed about 2,300 lives.
  3. The outbreak is caused by the Bundibugyo strain, which is not covered by the licensed Zaire‑strain vaccine Ervebo.
  4. WHO has deployed more than 40 experts and sent 12 tonnes of PPE, medicines and equipment to the affected zones.
  5. WHO Director‑General Tedros Adhanom Ghebreyesus will convene an emergency meeting to prioritise vaccine candidates.
  6. Ervebo, the WHO‑approved Zaire‑strain vaccine, could be available only after roughly two months of preparation.

Background

Ebola outbreaks test global health governance. The WHO, under the International Health Regulations, coordinates vaccine assessment, supplies and technical advice, while NGOs like MSF provide on‑ground care. The strain mismatch highlights the need for flexible vaccine platforms and rapid regulatory pathways.

UPSC Syllabus

  • Prelims_GS — International Current Affairs
  • GS2 — Important international institutions and agencies
  • Essay — Youth, Health and Welfare
  • Prelims_GS — Biology and Health

Mains Angle

GS2 – International Relations: Discuss how the WHO’s emergency mechanisms and public‑private partnerships shape global health security, especially when existing vaccines are strain‑specific.

Explore:Current Affairs·Editorial Analysis·Govt Schemes·Study Materials·Previous Year Questions·UPSC GPT
WHO Examines Vaccine Options as Ebola Outb... | UPSC Current Affairs